Adaltis receives favourable report for diagnostic test for HIV

03-Aug-2006

Adaltis Inc. announced that a product evaluation report published by the Microbiological diagnostics Assessment Service, has ranked Adaltis' fourth generation test for HIV screening - the Detect-HIV(TM) (v.4) - as the second most sensitive microplate product among the diagnostic kits tested by the Service.

Detect-HIV(TM) (v.4) is an ultra-sensitive EIA test offering a sensitivity of 100% and a specificity of greater than 99.8%, for detection of all HIV antibodies types and subtypes tested and for the detection of antigen p24 to HIV-1. The report will expand new market opportunities for Detect-HIV(TM) (v.4) internationally.

Other news from the department research and development

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

View topic world
Topic world Diagnostics

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.